AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
BEVACIZUMAB in Tunisia
4 products registered with DPM — 0 active, 4 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ABEVMY Solution à diluer pour perfusion / 400 mg(25mg/ml) | 20343022H | MYLAN PHARMACEUTICALS PRIVATE LIMITED | expired | 6 Sept 2021 |
| ABEVMY Solution à diluer pour perfusion / 100 mg(25mg/ml) | 20343021H | MYLAN PHARMACEUTICALS PRIVATE LIMITED | expired | 6 Sept 2021 |
| AVASTIN Solution injectable pour perfusion / 400 mg | 6993192H | Roche Pharma (Schweiz) AG | expired | 22 Sept 2010 |
| AVASTIN Solution injectable pour perfusion / 100 mg | 6993191H | Roche Pharma (Schweiz) AG | expired | 22 Sept 2010 |
BEVACIZUMAB — DPM Registration Details
DPM (Tunisia) has 4 registered products containing BEVACIZUMAB, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track BEVACIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.